Huang Jane has filed 28 insider transactions across 2 companies since January 2024.
Most recent transaction: a tax payment of 3355 shares of Prelude Therapeutics Inc ($PRLD) on October 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3355 | $1.47 | 86,917.0000 | 76,132,337 | 3.72% | 0.00% |
| Oct. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 90,272.0000 | 76,132,337 | 11.59% | 0.01% |
| Oct. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 18,750.0000 | 76,132,337 | 33.33% | 0.01% |
| July 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3355 | $0.79 | 80,897.0000 | 75,805,840 | 3.98% | 0.00% |
| July 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 28,125.0000 | 75,805,840 | 25.00% | 0.01% |
| July 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 84,252.0000 | 75,805,840 | 12.52% | 0.01% |
| June 12, 2025 | Protara Therapeutics, Inc. | $PRTO | Huang Jane | Not found | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 40,707,937 | 9999.99% | 0.06% |
| April 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3355 | $0.68 | 74,877.0000 | 75,805,840 | 4.29% | 0.00% |
| April 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 37,500.0000 | 75,805,840 | 20.00% | 0.01% |
| April 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 78,232.0000 | 75,805,840 | 13.62% | 0.01% |
| Feb. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 75,805,840 | 9999.99% | 0.26% |
| Jan. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 72,716.0000 | 75,805,840 | 14.80% | 0.01% |
| Jan. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3859 | $1.39 | 68,857.0000 | 75,805,840 | 5.31% | 0.01% |
| Jan. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 46,875.0000 | 75,805,840 | 25.00% | 0.01% |
| Oct. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 56,250.0000 | 75,855,949 | 14.29% | 0.01% |
| Oct. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3349 | $2.00 | 63,341.0000 | 75,855,949 | 5.02% | 0.00% |
| Oct. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 66,690.0000 | 75,855,949 | 16.36% | 0.01% |
| July 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3347 | $3.60 | 57,315.0000 | 60,357,052 | 5.52% | 0.01% |
| July 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 60,662.0000 | 60,357,052 | 18.28% | 0.02% |
| July 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 65,625.0000 | 60,357,052 | 12.50% | 0.02% |
| June 7, 2024 | Protara Therapeutics, Inc. | $PRTO | Huang Jane | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 11,420,948 | 9999.99% | 0.09% |
| April 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 75,000.0000 | 60,357,052 | 11.11% | 0.02% |
| April 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3347 | $4.74 | 51,287.0000 | 60,357,052 | 6.13% | 0.01% |
| April 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 54,634.0000 | 60,357,052 | 20.71% | 0.02% |
| March 1, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 60,357,052 | 9999.99% | 0.29% |
| Jan. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 49,103.0000 | 60,357,052 | 23.60% | 0.02% |
| Jan. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | F | Common Stock | 3844 | $3.77 | 45,259.0000 | 60,357,052 | 7.83% | 0.01% |
| Jan. 4, 2024 | Prelude Therapeutics Inc | $PRLD | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 84,375.0000 | 60,357,052 | 10.00% | 0.02% |